Home > Global Consortium Inc. GCGX

Tag: Global Consortium Inc. GCGX

FridayMay 17, 2019 12:16 pm

Global Consortium Inc. (GCGX) Expands Reach, Building First-Ever Cannabis Mall

The company is constructing the first-ever cannabis mall, offering products manufactured in-house and serving outside vendors GCGX is reaching into the Lake Tahoe, California-area to provide products to more than 30 million who have limited or no access to recreational dispensaries The company is adding a medical grade nutraceutical division GCGX aims to commence the registration process for listing on the Nasdaq, with a target date of mid- to late-June Headquartered in Florida, Global Consortium Inc. (OTC: GCGX) is a diversified, cannabis-holding company expanding its reach nationwide. The company’s portfolio includes several subsidiaries, partnerships and licensing agreements. Focused on sustainable…

Continue Reading

WednesdayMay 08, 2019 11:42 am

Global Consortium Inc. (GCGX) Finalizing Financial Reports, Anticipates Registration Process for Nasdaq Listing

The company’s annual license for manufacturing recreational and medicinal cannabis products was recently renewed by the State of California GCGX’s cannabis mall is under construction in Sacramento, with a goal of beginning production of Infused Edibles products there by the end of the second quarter The company’s ultimate goal is to be listed and traded on the Nasdaq Diversified cannabis holding company Global Consortium Inc. (OTC: GCGX) remains committed to its goal of beginning the registration process to be listed and traded on the Nasdaq by mid- to late-June of this year, CEO Matthew Dwyer said during an investor conference…

Continue Reading

MondayApr 22, 2019 11:24 am

Worldwide Nutraceuticals Market Continues Rapid Growth, Global Consortium Inc. (GCGX) Positioned to Benefit from Positive Dynamics

Nutraceuticals market growth is anticipated to create new opportunities for companies that are already well-established in the industry Recently, Global Consortium announced the addition of a medical-grade nutraceutical division to its subsidiary, Infused Edibles The new nutraceutical formulas will be developed and tested at a California facility prior to hitting the market, with the first product expected to become available in June 2019 The global nutraceuticals market is anticipated to grow from $184.0 billion in 2015 to $302.3 billion in 2022, recording a CAGR of 7.04 percent for the period, according to an Allied Market Research report (http://ibn.fm/f7uXb). According to…

Continue Reading

ThursdayApr 11, 2019 11:00 am

Global Consortium Inc. (GCGX) Establishes New Nutraceuticals Line, Explores Taking One Division Public in Canada

GCGX is a diversified cannabis holding company with $100 million in projected revenue for 2019 The company’s nutraceuticals division is to be overseen by medical physicians and veterinarians focused on diverse specialties GCGX’s product line is developed with proprietary infused formulas to include lotions, balms, ointments, liquids, pills and powders Discussions are underway to take one of the company’s divisions public in Canada in order to raise capital and open up growth potential From its headquarters in Florida, Global Consortium Inc. (OTC: GCGX), a diversified cannabis holding company expanding its reach nationwide with several subsidiaries, is evaluating an opportunity to…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .